VION Biosciences completes acquisition of BioAssay Systems to enhance product offering in life science research
Acquiring Company
VION Biosciences
Acquired Company
BioAssay Systems
CharlottesvilleBiotechnologyLife ScienceBiotechnologyLife ScienceDescription
VION Biosciences, a life science platform company, has announced the acquisition of San Francisco area-based BioAssay Systems. This acquisition enhances VION’s proprietary product offering in the life science research field, strengthening its core strengths in drug discovery and research. The acquisition will provide reliable, high-quality solutions for critical research in the life science space and contributes to VION’s domestic and global expansion efforts.
Quick answer
VION Biosciences is acquiring BioAssay Systems, announced February 5, 2025. VION Biosciences is based in Charlottesville, Virginia, United States.
- How much did VION Biosciences pay for BioAssay Systems?
- The deal value was not disclosed.
- What does VION Biosciences do?
- VION Biosciences is a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space.
- Where are VION Biosciences and BioAssay Systems based?
- VION Biosciences is based in Charlottesville, Virginia, United States.
- Who are the decision-makers at VION Biosciences?
- Fundz holds 1 contact at VION Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Life Science and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- MediSpend strengthens Governance, Risk and Compliance Solutions through Acquisition of Real Life Sciences (January 27, 2025)
- Takara Bio USA Holdings, Inc. acquires Curio Bioscience, expanding its single-cell omics solutions with spatial biology (January 15, 2025)
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio (January 6, 2025)
- Alvotech acquires Xbrane's R&D operations in Sweden (March 20, 2025)
- START acquires Carolina Urologic Research Center (March 18, 2025)
Who to call at VION Biosciences, and when
When VION Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day VION Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VION Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VION Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VION Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BioAssay Systems?
BioAssay Systems was acquired by VION Biosciences, based in Charlottesville. The deal was reported on February 5, 2025. VION Biosciences is a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space. VION Biosciences is privately held and operates in Biotechnology.
When did VION Biosciences acquire BioAssay Systems?
VION Biosciences's acquisition of BioAssay Systems was reported on February 5, 2025. VION Biosciences, a life science platform company, has announced the acquisition of San Francisco area-based BioAssay Systems. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BioAssay Systems do?
BioAssay Systems is a biotech company that develops and offers innovative high-throughput assay solutions for life sciences and drug discovery. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.